| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.78 | 0.0009 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |